Evidence map›Paper›PMID 38632039›Full record

ArticleJournal of industrial microbiology & biotechnology2024

Unlocking growth potential in Halomonas bluephagenesis for enhanced PHA production with sulfate ions.

Fuwei Yao, Kai Yuan, Weiqiang Zhou, Weitao Tang, Tang Tang, Xiaofan Yang, Haijun Liu, Fangliang Li, Qing Xu, Chao Peng

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fuwei YaoSchool of food science and pharmaceutical engineering, Nanjing Normal University (NNU), Nanjing, 210023, China.ORCID 0009-0007-8973-1510
Kai YuanBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Weiqiang ZhouBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Weitao TangBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Tang TangBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Xiaofan YangBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Haijun LiuBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Fangliang LiBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.
Qing XuSchool of food science and pharmaceutical engineering, Nanjing Normal University (NNU), Nanjing, 210023, China.
Chao PengBiotechnology Center, COFCO Nutrition and Health Research Institute Co., Ltd., Beijing, 102209, China.ORCID 0009-0008-2898-3180

Funding

National Key Research and Development Program of China 2021YFC2101702Science and Technology Bureau of Jilin Province of China 20220201107GX
6 · The paper itself

Abstract

The mutant strain Halomonas bluephagenesis (TDH4A1B5P) was found to produce PHA under low-salt, non-sterile conditions, but the yield was low. To improve the yield, different nitrogen sources were tested. It was discovered that urea was the most effective nitrogen source for promoting growth during the stable stage, while ammonium sulfate was used during the logarithmic stage. The growth time of H. bluephagenesis (TDH4A1B5P) and its PHA content were significantly prolonged by the presence of sulfate ions. After 64 hr in a 5-L bioreactor supplemented with sulfate ions, the dry cell weight (DCW) of H. bluephagenesis weighed 132 g/L and had a PHA content of 82%. To promote the growth and PHA accumulation of H. bluephagenesis (TDH4A1B5P), a feeding regimen supplemented with nitrogen sources and sulfate ions with ammonium sodium sulfate was established in this study. The DCW was 124 g/L, and the PHA content accounted for 82.3% (w/w) of the DCW, resulting in a PHA yield of 101 g/L in a 30-L bioreactor using the optimized culture strategy. In conclusion, stimulating H. bluephagenesis (TDH4A1B5P) to produce PHA is a feasible and suitable strategy for all H. bluephagenesis.

Indexed as

BioreactorsCulture MediaHalomonasNitrogenPolyhydroxyalkanoatesSulfatesAmmonium SulfateFermentationUreaAmmonium SulfateCulture MediaNitrogenPolyhydroxyalkanoatesSulfatesUreaFermentation scale-upHalomonas bluephagenesisPolyhydroxyalkanoateSulfate ions

Identifiers

PMID38632039
PMCPMC11074995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.